PTCT
Ptc Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.27 / 10
Netural
Analyst coverage is overwhelmingly bullish (100% Buy), yet sentiment score is only 4.27, reflecting a neutral stance. Fund flow is strong at 7.73/10, with positive block, small, and large trends despite negative medium and extra-large patterns. This suggests institutional accumulation but also short-term distribution pressure.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-28
InstitutionBarclays
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for PTCT?
- PTCT holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.27/10 (Netural).
